ALB and non-small cell lung carcinoma: Originally designed to evaluate the degree of systemic inflammation in patients with metastatic non-small cell lung cancer (NSCLC) (10), ALI is computed using the formula: body mass index (BMI) multiplied by serum albumin (Alb) divided by the neutrophil to lymphocyte ratio (NLR).